Initiatives and programs
We're working on a range of policy initiatives, programs and campaigns to help improve your health and the health of all Australians.
The National Tobacco Campaign aims to reduce smoking rates in Australia. It is part of our National Tobacco Strategy.
The Australian Brain Cancer Mission is a $124 million fund that supports research into brain cancer treatments. It aims to double the survival rate of Australians living with brain cancer over the next 10 years.
The Comprehensive Palliative Care in Aged Care measure aims to help older Australians living in residential aged care, nearing end of their life.
The Continence Aids Payment Scheme (CAPS) provides a payment to help with some of the costs of your continence products.
The National Continence Program (NCP) is a national program to support the prevention and management of incontinence.
The Cardiovascular Health Mission will invest $220 million over 10 years to bring together researchers, health professionals, industry and patients to make transformative improvements in heart and vascular health and stroke for all Australians.
The Global Health initiative will invest $28.4 million over 10 years to fund projects that improve our understanding of global health threats and how best to tackle them. The initial focus is on tackling antimicrobial resistance and drug-resistant tuberculosis.
The Indigenous Health Research Fund (IHRF) is investing in Indigenous-led research to tackle health issues facing Aboriginal and Torres Strait Islander people.
The Medical Research Commercialisation initiative supports innovative early stage health and medical research in Australia. It helps researchers transform their ideas into life-saving medicines, devices and treatments to help tomorrow’s patients.
This initiative provides funding for research infrastructure that will be used to conduct world-class health and medical research. It includes funding for facilities in rural and remote areas so that people can participate in clinical trials without the need to travel to a major city.
This initiative supports targeted research on new ways to address risk factors for chronic and complex diseases in Australia.
The Primary Health Care Research initiative will increase Australia’s evidence base in primary health care through research to improve service delivery and patient outcomes, and translate this knowledge into action.
The Research Data Infrastructure initiative will fund the creation or extension of research data infrastructure with a focus on data registries, biobanks and data linkage platforms to support Australian medical research. It will provide $80 million over 8 years, starting in 2020–21.
Rare Cancers, Rare Diseases and Unmet Need Clinical Trials has been consolidated into the Clinical Trials Activity initiative under the MRFF 10-year plan.
Real Time Prescription Monitoring (RTPM) is a computer system that aims to reduce misuse of controlled medicines in Australia. It will alert prescribers and pharmacists to a patient’s medication history before they write or dispense prescriptions for a controlled medicine.
The Australian Government is investing in a pilot program to make naloxone available free to people who may experience, or witness, an opioid overdose.
This funded website provides current, authoritative and evidence-based information about fetal alcohol spectrum disorders (FASD). It has resources for parents and carers, researchers, health professionals and health care providers.
This funded initiative encourages Australians to go alcohol-free during their pregnancy or the pregnancy of loved ones. It helps mums-to-be build a strong support system. It also raises awareness of the serious effects of alcohol during pregnancy.
The National Immunisation Program (NIP) was set up by the Commonwealth and state and territory governments in 1997. It aims to increase national immunisation coverage to reduce the number of cases of diseases that are preventable by vaccination in Australia.
Antimicrobial resistance (AMR) is a serious threat to human and animal health and is happening now. The more we use antibiotics, the more chances bacteria have to become resistant to them and are harder to treat. We all need to take action to preserve antibiotics and reduce the threat of AMR.